Geen na
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy, lean (BMI 18-25 kg/m2) adults Age: 18-30 years Male and female For females: use of a specific oral contraceptive (Microgynon 30 or levonorgestrel/ethinylestradiol) Caucasian Sedentary (=
Exclusion criteria
Exclusion criteria: Cardiovascular diseases Hypertension (systolic/diastolic blood pressure > 140/90) Hypotension (systolic/diastolic blood pressure 5.6 mmol/l) Hyperthyroidism Pregnancy Participation in earlier research or medical examinations that included PET/CT scanning Radiation therapy due to medical treatment Unstable body weight (weight gain or loss >3kg in the past 2 months) Any known or suspected obstructive disease of the gastrointestinal tract, hypo motility disorders of the gastrointestinal tract or previous gastrointestinal surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameters are: - Standard uptake value (SUV) of BAT: This is used as a measure of BAT glucose uptake and BAT activity and will be measured by means of FDG-PET/CT scanning. - Skeletal muscle mitochondrial respiration/uncoupling: This will be determined in skeletal muscle samples using the Oroboros 2k Oxygraph instrument present in our laboratroy. - Energy expenditure: This will be measured by means of indirect calorimetry using a ventilated hood. - Ex vivo skeletal muscle glucose oxidation: This will be measured to determine insulin sensitivity. A glucose oxidation assay with insulin stimulation will be performed in skeletal muscle biopsies. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters include: -Body temperatures: Skin temperatures will be measured by means of iButtons and core temperature will be determined by ingestion of a telemetric pill. - Skin perfusion: This will be measured by means of LaserDoppler flowmetry. - Blood parameters: Venous blood will be drawn by means of a catheter placed in the antercubital vein of the underarm. By using radioimmunoassay and high performance liquid chromatography blood parameters will be analyzed. - UCP-1 and beta3-receptor polymorphims | — |
Countries
Netherlands